Tongde Capital is an investment firm that engaged in investment management and consulting.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 4, 2022
Bichen Pharmaceutical
|
Series B | $30M | Biopharma | — |
Jul 1, 2017
RunFox
|
Angel | ¥10M | Children | Yes |
Jun 26, 2015
Hengda Gufen
|
Post-IPO Equity | ¥76M | Manufacturing | — |
Tongde Capital has had 1 exits. Tongde Capital most notable exits include Hengda Gufen
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 15, 2015 | Hengda Gufen | IPO | Manufacturing | Detail |